Evidence-Based Robot-Assistant in Neurorehabilitation (NCT05152433) | Clinical Trial Compass
UnknownNot Applicable
Evidence-Based Robot-Assistant in Neurorehabilitation
Germany40 participantsStarted 2021-10-04
Plain-language summary
The purpose of this study is to investigate the efficacy, acceptability, and safety of the therapeutic system E-BRAiN for the treatment of stroke-related impairments.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age at study entry ≥ 18 years
* Stroke (ischemic stroke, non-traumatic intracerebral haemorrhage, subarachnoidal haemorrhage)
* Incomplete arm paresis (Motricity Index, arm score \>1 \[Min\] and \< 100 \[Max\]) or
* Visuospatial neglect (clinical signs and NET subtest "star cancellation" score \< 50)
* Candidate able to consent and provides informed consent or
* legal representative provides informed consent
Exclusion Criteria:
* Pregnant or breast feeding
* Obliged to live in an institution by law or public authority
* With case presentation arm paresis: another condition that causes arm paresis is present
* With case presentation visuospatial neglect: another condition that causes a relevant visual-perceptual deficit that cannot be compensated is present; exception: homonymous visual field deficits are not an exclusion criterion
What they're measuring
1
Change scores over two weeks for the standardised primary outcome measure